Pyxis Oncology Inc (PYXS) Implied Volatility Current

Tracking PYXS implied volatility helps you identify when options premiums on Pyxis Oncology Inc are historically cheap or expensive, and where the best trades are hiding. Pyxis Oncology Inc implied volatility reflects the market's expectation of future price movement: when PYXS IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Pyxis Oncology Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PYXS, tracking metrics like PYXS IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PYXS signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therapeutic for treatment of solid tumors. The company's antibody drug conjugate (ADC) product candidates comprise of PYX-201, an investigational novel ADC to treat NSCLC, breast cancer, and other solid tumors; PYX-202, an investigational novel ADC for treatment of SCLC, soft tissue sarcoma, and other solid tumors; and PYX-203, an investigational ADC for the treatment of acute myeloid leukemia and myeloid dysplastic syndrome.

The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PYXS implied volatility sits today versus where it has been. Our scanner ranks Pyxis Oncology Inc implied volatility against its historical range, surfaces extremes in PYXS IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Pyxis Oncology Inc IV is rich or cheap — measure it, then act on it.